IV 1,097 Aim: to assess knowledge and risk behaviour Among respondents (response 66.0%), 12.5% (Pereboom et al related to toxoplasmosis, listeriosis and CMV had heard, read or seen information about 2013) infection prevention in pregnant women. CMV. The majority reported having heard about these infections from their care Population: Pregnant women. providers or read about these in printed media Methods: Women from twenty midwifery or on the Internet. Respondents showed practices across the Netherlands participated in limited knowledge about preventive practices the DELIVER study, between October 2010 and for CMV infection. Regarding CMV infections, December 2010. The questionnaire items risk behaviour was less prevalent among covered respondents' knowledge of preventive respondents who were in their third trimester practices in general, risk behaviour, and sources of pregnancy. of received information. IV 774 Aim: To assess the knowledge, practice and Overall, 30.2% felt confident discussing (Shand et al attitudes of maternity clinicians regarding CMV in pregnancy: less than 10% of midwives 2018) congenital cytomegalovirus (CMV). It is the most (7.4%) and less than half of specialists (47.1%, common congenital infection, and p < .0001). Only 8.8% of respondents routinely cause of neurodevelopmental discussed CMV prevention with pregnant disability and hearing loss. New consensus women. The majority (69.3%) responded that recommendations state all pregnant women and professional societies should make practice health-care providers should be educated about recommendations, and 88% thought more congenital CMV infection and preventive patient information was needed, preferably measures. leaflets. Methods: An questionnaire was distributed in October 2015 to specialists (37.3%), general practitioners (17.3%), and trainees of the Royal Australian New Zealand College of Obstetricians and Gynaecologists (16.8%), and Victorian and New South Wales midwives (28.6%). Evidence table: Hyperimmunoglobulin Study ref Design LoE N Aim/population/methods Results Comments
(Pereboom et al 2013) IV 1,097 Aim: to assess knowledge and risk behaviour related to toxoplasmosis, listeriosis and CMV infection prevention in pregnant women. Population: Pregnant women. Methods: Women from twenty midwifery practices across the Netherlands participated in the DELIVER study, between October 2010 and December 2010. The questionnaire items covered respondents' knowledge of preventive practices in general, risk behaviour, and sources of received information. Among respondents (response 66.0%), 12.5% had heard, read or seen information about CMV. The majority reported having heard about these infections from their care providers or read about these in printed media or on the Internet. Respondents showed limited knowledge about preventive practices for CMV infection. Regarding CMV infections, risk behaviour was less prevalent among respondents who were in their third trimester of pregnancy. (Shand et al 2018) IV 774 Aim: To assess the knowledge, practice and attitudes of maternity clinicians regarding congenital cytomegalovirus (CMV). It is the most common congenital infection, and cause of neurodevelopmental disability and hearing loss. New consensus recommendations state all pregnant women and health-care providers should be educated about congenital CMV infection and preventive measures. Methods: An questionnaire was distributed in October 2015 to specialists (37.3%), general practitioners (17.3%), and trainees of the Royal Australian New Zealand College of Obstetricians and Gynaecologists (16.8%), and Victorian and New South Wales midwives (28.6%). Overall, 30.2% felt confident discussing CMV in pregnancy: less than 10% of midwives (7.4%) and less than half of specialists (47.1%, p < .0001). Only 8.8% of respondents routinely discussed CMV prevention with pregnant women. The majority (69.3%) responded that professional societies should make practice recommendations, and 88% thought more patient information was needed, preferably leaflets. Evidence table: Hyperimmunoglobulin Study ref Design LoE N Aim/population/methods Results Comments
Cytomegalovirus%20evidence%20evaluation%2015Oct18.DOCX